 A Open-label, Randomized, Single-dose, 2x2 Crossover Study to Compare the Pharmacokinetics and Safety between a Fixed Dose Combination of FimasartanAmlodipineRosuvastatin versus Co-administration of a Fixed Dose Combination of FimasartanAmlodipine and Rosuvastatin in Healthy Male Subjects. 